Header

UZH-Logo

Maintenance Infos

TP53 mutations confer resistance to hypomethylating agents and BCL-2 inhibition in myeloid neoplasms


Schimmer, Roman R. TP53 mutations confer resistance to hypomethylating agents and BCL-2 inhibition in myeloid neoplasms. 2022, University of Zurich, Faculty of Medicine.

Statistics

Downloads

32 downloads since deposited on 16 Jan 2023
24 downloads since 12 months
Detailed statistics

Additional indexing

Item Type:Dissertation (monographical)
Referees:Boettcher Steffen
Communities & Collections:04 Faculty of Medicine > University Hospital Zurich > Clinic for Clinical Pharmacology and Toxicology
UZH Dissertations
Dewey Decimal Classification:610 Medicine & health
Language:English
Date:2022
Deposited On:16 Jan 2023 15:37
Last Modified:21 May 2024 20:16
OA Status:Green
Free access at:Related URL. An embargo period may apply.
Related URLs:https://www.zora.uzh.ch/id/eprint/221976/
https://pubmed.ncbi.nlm.nih.gov/35026842/
https://ashpublications.org/bloodadvances/article/6/11/3201/483517/TP53-mutations-confer-resistance-to
  • Content: Published Version
  • Licence: Creative Commons: Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)